Loading: 100%
K2M GROUP HOLDINGS, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 523 (as per Q3 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker KTWOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 171518212427
datesClosing price (adj.)
13.10.201719.02
11.10.201718.76
04.10.201722.66
27.09.201721.59
20.09.201720.90
13.09.201722.71
06.09.201722.87
30.08.201723.11
23.08.201723.21
16.08.201724.05
09.08.201723.29
02.08.201721.94
26.07.201725.37
19.07.201724.76
12.07.201724.51
05.07.201723.73
27.06.201723.33
20.06.201723.28
13.06.201723.14
06.06.201722.81
30.05.201722.84
23.05.201722.14
16.05.201722.33
09.05.201721.45
02.05.201722.39
25.04.201722.05
18.04.201720.80
11.04.201721.28
04.04.201720.37
28.03.201719.93
21.03.201718.71
14.03.201719.81
07.03.201720.04
28.02.201720.05
21.02.201720.56
14.02.201720.69
07.02.201720.66
31.01.201720.32
24.01.201721.76
17.01.201721.77
10.01.201722.54
03.01.201720.34
27.12.201620.68
19.12.201619.88
12.12.201620.13
05.12.201620.27
28.11.201619.15
21.11.201618.84
14.11.201618.29
07.11.201619.03
31.10.201617.07
24.10.201618.92
17.10.201618.34
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
19.02n/a
Market Capitalisation
in million USD
803n/a
Enterprise Value
in million USD
829n/a
Common Shares Outstanding
as per Oct 27, 2016
42,197,647n/a
Preferred Shares Outstanding
as per Oct 27, 2016
n/a
Average Basic Shares Outstanding
TTM
41,554,917n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
K2M Group Holdings Inc is a medical device company. The Company is engaged in designing, developing and commercializing proprietary complex spine and minimally invasive technologies and techniques.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 46n/a
Receivables 43n/a
Total Current Assets 163n/a
PP&E 51n/a
Total Assets 391n/a
Accounts Payable 15n/a
Current Debt 1n/a
Total Current Liabilities 42n/a
Long-Term Debt 72n/a
Total Liabilities 119n/a
Total Equity 272n/a
Cash Flow
Depreciation & Amortisation 28n/a
Change in Working Capital -22n/a
Operating Cash Flow -20n/a
Net Change in PP&E and Intangibles -33n/a
Investing Cash Flow -27n/a
Dividends Paid 0n/a
Financing Cash Flow 50n/a
Total Change in Cash 2n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 6.55n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 2.90n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.34n/a
Other Ratios
Current Ratio 390.9%n/a
Liabilities to Equity Ratio 43.7%n/a
Debt to Assets Ratio 18.5%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
135
158
187
216
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-44
-50
-63
-72
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
91
107
124
144
Other Operating Income
0
0
0
0
Operating Expenses
-137
-152
-172
-180
Selling, General & Administrative
-128
-140
-156
-161
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-9
-12
-16
-20
Depreciation & Amortization
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-46
-45
-48
-36
Non-Operating Income (Loss)
0
1
7
3
Interest Expense, net
1
3
2
1
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
-1
-1
5
2
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
Pretax Income (Loss), Adjusted
-46
-44
-41
-34
Abnormal Gains (Losses)
10
19
-2
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-35
-24
-43
-34
Income Tax (Expense) Benefit, net
13
8
0
0
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-22
-16
-43
-34
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-22
-16
-43
-34
Minority Interest
0
0
0
0
Net Income
-22
-16
-43
-34
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-22
-16
-43
-34
Remarks
restated on Mar 18, 2015 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
Balance SheetBS data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
7
11
35
Cash & Cash Equivalents
n/a
7
11
35
Short Term Investments
n/a
0
0
0
Accounts & Notes Receivable
n/a
33
34
39
Accounts Receivable, Net
n/a
33
34
39
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
39
53
62
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
13
4
20
Prepaid Expenses
n/a
4
4
20
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
9
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
Total Current Assets
n/a
92
102
155
Property, Plant & Equipment, Net
n/a
3
4
38
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
202
193
181
Intangible Assets
n/a
0
42
33
Goodwill
n/a
186
122
122
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
15
30
26
Total Noncurrent Assets
n/a
205
197
219
Total Assets
n/a
297
299
375
Liabilities and owners' equity
Payables & Accruals
n/a
36 36225000
36 35583000
48 47549000
Accounts Payable
n/a
17 17069000
14 14018000
22 22483000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
19 19156000
22 21565000
25 25066000
Short Term Debt
n/a
0 0
0 0
0 284000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
24 23500000
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
24 23500000
0 0
0 0
Total Current Liabilities
n/a
60 59725000
36 35583000
48 47833000
Long Term Debt
n/a
20 19650000
0 0
34 34140000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
14 14295000
5 5154000
6 5877000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
14 14084000
5 5042000
5 5042000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 211000
0 112000
1 835000
Total Noncurrent Liabilities
n/a
34 33945000
5 5154000
40 40017000
Total Liabilities
n/a
94 93670000
41 40737000
88 87850000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
166 165673000
387 386832000
454 454194000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-71 -70568000
-130 -130205000
-169 -169421000
Other Equity
n/a
-1 -920000
2 1827000
2 1889000
Equity Before Minority Interest
n/a
94 94185000
258 258454000
287 286662000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
94 94185000
258 258454000
287 286662000
Total Liabilities & Equity
n/a
188 187855000
299 299191000
375 374512000
Remarks restated on n/a restated on Mar 18, 2015 n/a restated on Mar 4, 2016 n/a restated on Nov 2, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-33
-38
-60
-39
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
42
37
33
25
Non-Cash Items
-8
-3
12
13
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
-18
-15
-15
-17
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-16
-19
-30
-18
Change in Fixed Assets & Intangibles
-5
-10
-16
-14
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-7
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-5
-10
-23
-14
Dividends Paid
0
0
-19
0
Cash From (Repayment of) Debt
17
30
-48
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
0
-1
123
56
Increase in Capital Stock
0
-1
123
56
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
16
29
57
56
Net Cash Before Disc. Operations and FX
-5
0
4
24
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
-5
0
4
24
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
-5
0
4
23
Remarks
restated on Mar 18, 2015 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
restated on Mar 4, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo